Evidence map›Paper›PMID 34541587›Full record

ArticleProceedings of the 2014 6th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation : the CHIC Project Workshop (IARWISOCI) : Athens, Greece, 3-4 November 2014. International Advanced Research Workshop on...2014

Computational Horizons In Cancer (CHIC): Developing Meta- and Hyper-Multiscale Models and Repositories for

G Stamatakos, Dimitra Dionysiou, Fay Misichroni, Norbert Graf, Stefaan van Gool, Rainar Bohle, Feng Dong, Marco Viceconti, Kostas Marias, Vangelis Sakkalis and 10 more

Abstract read
In one paragraph

Article in Proceedings of the 2014 6th International Advanced Research Workshop on In Silico Oncology and Cancer Investigation : the CHIC Project Workshop (IARWISOCI) : Athens, Greece, 3-4 November 2014. International Advanced Research Workshop on..., 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

G StamatakosIn Silico Oncology Group, Institute of Communication and Computer Systems, National Technical University of Athens, Greece.
Dimitra DionysiouIn Silico Oncology Group, Institute of Communication and Computer Systems, National Technical University of Athens, Greece.
Fay MisichroniIn Silico Oncology Group, Institute of Communication and Computer Systems, National Technical University of Athens, Greece.
Norbert GrafUniversity of Saarland, Pediatric Oncology and Hematology Clinic, Germany.
Stefaan van GoolCatholic University of Leuven, Pediatric Oncology Clinic, Belgium.
Rainar BohleUniversity of Saarland, Dept. of Pathology, Germany.
Feng DongUniversity of Bedfordshire, UK.
Marco VicecontiUniversity of Sheffield, UK.
Kostas MariasFoundation for Research and Technology, Hellas, Greece.
Vangelis SakkalisFoundation for Research and Technology, Hellas, Greece.
Nikolaus ForgoG.W.Leibnitz University of Hannover, Germany.
Ravi RadhakrishnanUniversity of Pennsylvania, USA.
Helen ByrneUniversity of Oxford, UK.
Caterina GuiotUniversity of Torino.
Philippe BuechlerUniversity of Bern, Switzerland.
Elias NeriCustodix NV, Belgium.
Anca BucurPhilips Electronics Nederland B.V., The Netherlands.
Bernard de BonoUniversity College London, UK.
Debora TestiConsorzio Universitario CINECA, Italy.
Manolis TsiknakisTechnological Educational Institute of Crete, Greece.

Funding

A plasticity and reprogramming paradigm for therapy resistance at the single cell levelU01CA227550 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RADHAKRISHNAN, RAVI, RAJ, ARJUN · 2018 to 2022
$3.3M
NCI NIH HHS U01 CA227550
6 · The paper itself

Abstract

This paper briefly outlines the aim, the objectives, the architecture and the main building blocks of the ongoing large scale integrating transatlantic research project CHIC (http://chic-vph.eu/).

Identifiers

PMID34541587
PMCPMC8444280

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.